Evidence map›Paper›PMID 9087504›Full record

ArticleAntimicrobial agents and chemotherapy1997

In vitro activity of fluvastatin, a cholesterol-lowering agent, and synergy with flucanazole and itraconazole against Candida species and Cryptococcus neoformans.

N X Chin, I Weitzman, P Della-Latta

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 101 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Antimicrobial effects of sophorolipid in combination with lactic acid against poultry-relevant isolates.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Honey Antibacterial Effect Boosting UsingEvidence-based complementary and alternative medicine : eCAM · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

N X ChinMycology Resource Center, Columbia-Presbyterian Medical Center, New York, New York 10032, USA.
I Weitzman
P Della-Latta
NewYork–Presbyterian Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fluvastatin, a cholesterol-lowering drug, exhibited minimal activity (MICs of 64 to >128 microg/ml) against Candida species and Cryptococcus neoformans. When fluvastatin was combined with fluconazole or itraconazole, both synergistic and additive effects were noted (fractional inhibitory concentration indices of < or = 0.156 to 0.625; fractional lethal concentration indices of < or = 0.156 to 0.75). This combined fungicidal activity was confirmed by time-versus-killing studies.

Indexed as

Anticholesteremic AgentsAntifungal AgentsCandidaCryptococcus neoformansDrug SynergismFatty Acids, MonounsaturatedFluconazoleFluvastatinIndolesItraconazoleMicrobial Sensitivity TestsTime FactorsAnticholesteremic AgentsAntifungal AgentsFatty Acids, MonounsaturatedFluconazoleFluvastatinIndolesItraconazole

Identifiers

PMID9087504
PMCPMC163809
OpenAlexW2122563248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.